← Back to Search

Group Therapy for Traumatic Injury

N/A

Waitlist Available

Led By Rosalie Steinberg, MSc, MD

Research Sponsored by Sunnybrook Health Sciences Centre

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Trauma-related peripheral nerve injury, muscle injury, amputation, and/or fracture(s)

English speaking adults aged 18 years and older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year.

Awards & highlights

Study Summary

This trial will test if group therapy helps trauma survivors cope better with life’s challenges. 60 patients with traumatic injuries will get either group therapy or standard care. The goal is to improve physical, mental and social health in the community.

Who is the study for?

This trial is for English-speaking adults over 18 who are in rehab at St. John's Rehab due to traumatic injuries like nerve damage, muscle injury, amputation, or fractures. They should be mentally stable without severe mental health issues or cognitive impairments and not actively suicidal or unable to participate in group settings.Check my eligibility

What is being tested?

The study tests if supportive-expressive group therapy helps trauma patients better cope with life after their injury compared to standard care. It involves randomly placing 60 patients into two groups: one receives the therapy and the other gets usual rehabilitation treatment.See study design

What are the potential side effects?

Since this trial involves psychological support rather than medication, side effects may include emotional discomfort during discussions but no physical side effects are expected from the therapy itself.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had a trauma-related injury to my nerves, muscles, lost a limb, or broken bones.

Select...

I am 18 or older and speak English.

Select...

I am admitted to SJR for inpatient rehab.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year.

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Barriers and Facilitators to Group Participation

Number of participants contacted for follow up interview

Participant Retention

+4 more

Secondary outcome measures

Change in Health-related quality of life

Change in coping self-efficacy

Marriage, life event

+2 more

Other outcome measures

Change in Injury Severity

Change in Personality

Change in experiences in close relationships

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Supportive-expressive group therapyExperimental Treatment1 Intervention

The SEGT is a six-module program where each session is approximately one hour, and is held twice a week over a three-week period. It is framed within social cognitive theory, whereby resilience to adversity (NMSK trauma in this instance) relies on personal enablement. Enablement serves to equip the individual with the personal resources to cultivate their self-efficacy and mastery and to select and construct environments that promote successful adaption.

Group II: Treatment as usualActive Control1 Intervention

The treatment as usual group will receive standard care only (which may include an individual psychiatric consultation).

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor

656 Previous Clinical Trials

1,551,252 Total Patients Enrolled

Rosalie Steinberg, MSc, MDPrincipal InvestigatorSunnybrook Health Sciences Centre

Media Library

Supportive Expressive Group Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05320445 — N/A

Traumatic Injury Research Study Groups: Supportive-expressive group therapy, Treatment as usual

Traumatic Injury Clinical Trial 2023: Supportive Expressive Group Therapy Highlights & Side Effects. Trial Name: NCT05320445 — N/A

Supportive Expressive Group Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05320445 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the desired outcome of this trial?

"The primary outcome that will be assessed over the duration of this clinical trial (est. 1 year) is patient questionnaire completion rates. Secondary objectives include changes in impact of traumatic life events as measured by the Impact Event Scale Revised, post-traumatic growth tracked with Post Traumatic Growth Inventory, and PTSD symptoms evaluated via the Post-Traumatic Stress Disorder Checklist - Civilian Version."

Answered by AI

Does this experiment still have room for new participants?

"Indeed, the information available from clinicaltrials.gov attests that this medical trial is currently in its recruitment phase. First posted back on January 23rd 2023 and last edited on July 6th of the same year, it aims to acquire 60 participants across one location."

Answered by AI

What is the current quota of participants for this research endeavor?

"Affirmative, the information provided on clinicaltrials.gov showcases that this medical trial is currently recruiting individuals. It was initially posted on January 23rd 2023 and most recently updated July 6th 2023. The investigation requires 60 participants to be enrolled at 1 site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Psychosocial Transitional Group to Improve Adaptation, Coping and Mental Health Outcomes Following Trauma

2023. "A Psychosocial Transitional Group to Improve Adaptation, Coping and Mental Health Outcomes Following Trauma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05320445.